title: Bowel Perforation After Treatment with Sorafenib: A Case Report and Review of Literature.
authors.affiliation: Department of Internal Medicine, Creighton University School of Medicine, 601 N. 30th Street Suite 5850, Omaha, NE, 68131, USA. shadihamdeh@creighton.edu.
authors.forename: Shadi
authors.initials: S
authors.lastname: Hamdeh
authors.affiliation: Department of Internal Medicine, Creighton University School of Medicine, 601 N. 30th Street Suite 5850, Omaha, NE, 68131, USA.
authors.forename: Smrity
authors.initials: S
authors.lastname: Upadhyay
authors.affiliation: Department of Internal Medicine, Creighton University School of Medicine, 601 N. 30th Street Suite 5850, Omaha, NE, 68131, USA.
authors.forename: Nabin
authors.initials: N
authors.lastname: Khanal
authors.affiliation: Department of Internal Medicine, Creighton University School of Medicine, 601 N. 30th Street Suite 5850, Omaha, NE, 68131, USA.
authors.forename: Stephen
authors.initials: S
authors.lastname: Lanspa
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007416:Intestinal Perforation / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010671:Phenylurea Compounds / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib